In the terms of prognostic role, since the over-expression of immune checkpoint stimulator was always associated with a better survival time of tumor patients, these two opposite conclusions about HHLA2 function make the exact prognostic role of HHLA2 still uncertain. The gene discussed is HHLA2; the disease is neoplasm.